Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Pozycja w akcjach #5874
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Cena akcji
$17.88
Kapitalizacja rynkowa
$2.32B
Zmiana (1 dzień)
-3.04%
Zmiana (1 rok)
-
Kraj
US
Handel Kailera Therapeutics, Inc. (KLRA)

Kategoria

Historia stopy dywidendy dla Kailera Therapeutics, Inc. (KLRA)
Stopa dywidendy (TTM) dla Kailera Therapeutics, Inc. (symbol akcji: KLRA) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Kailera Therapeutics, Inc. (KLRA) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji